文献速递胸部肿瘤放疗放疗物理与技术

IMRT与质子治疗后肺损伤的18F-FDG PET显像差异

Differences in lung injury after IMRT or proton therapy assessed by 18FDG PET imaging.
PubMed 文献 · Radiother Oncol · 2018-01-16

本研究纳入83例接受IMRT或质子治疗的NSCLC患者,将治疗后18F-FDG PET-CT与计划CT配准进行体素级分析,比较两种模态的肺损伤及预测症状性放射性肺炎的因素。结果显示两种模态剂量分布显著不同(IMRT的V5更高、质子V60更高),但FDG摄取-剂量线性回归斜率无显著差异;发生放射性肺炎患者的MLD和斜率均显著更高,且与治疗模态无关。

要点

  • IMRT与质子的剂量分布显著不同:IMRT的V5更高,质子V60更高。
  • 两种模态的18F-FDG摄取-剂量线性回归斜率无显著差异。
  • MLD、斜率和SUV第95百分位数是与放射性肺炎相关的三个主要因素。

核心结论

  • 尽管IMRT与质子的剂量分布显著不同,先前显示与放射性肺炎相关的SUV-剂量线性回归斜率在两种模态间无差异。
  • 发生放射性肺炎的患者MLD和斜率均显著更高,且与治疗模态无关。

研究设计与样本

  • 回顾性分析83例接受IMRT或质子治疗的NSCLC患者,将计划CT与治疗后18F-FDG PET-CT配准,建立PET与计划剂量图像的体素级对应关系。
  • 获取每位患者正常肺18F-FDG摄取随辐射剂量的变化,并将PET衍生参数及人口学、临床、治疗和剂量学特征与肺炎临床症状进行相关性分析。

主要发现

  • 两种模态剂量分布显著不同:IMRT的V5更高,质子V60更高;两种模态的平均肺剂量(MLD)相似。
  • 18F-FDG摄取-剂量线性回归斜率在两种模态间无显著差异。
  • MLD、斜率和SUV第95百分位数被确定为与放射性肺炎相关的三个主要因素。

关键数值与推荐

  • V5在IMRT中更高,V60在质子中更高;两种模态的MLD相似。
  • 发生放射性肺炎的患者MLD和斜率均显著更高,且与治疗模态无关。

临床怎么用

  • 治疗后18F-FDG PET-CT可用于评估正常肺的剂量-摄取反应,MLD、SUV-剂量斜率和SUV第95百分位数有助于识别放射性肺炎高风险患者。
  • IMRT与质子的剂量分布差异(V5与V60)未导致SUV-剂量斜率差异,选择模态时可结合其他剂量学因素综合考量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: To compare lung injury among non-small cell lung cancer (NSCLC) patients treated with IMRT or proton therapy as revealed by 18F-FDG post-treatment uptake and to determine factors predictive for clinically symptomatic radiation pneumonitis. MATERIAL AND METHODS: For 83 patients treated with IMRT or proton therapy, planning CT and follow up 18F-FDG PET-CT were analyzed. Post-treatment PET-CT was aligned with planning CT to establish a voxel-to-voxel correspondence between PET and planning dose images. 18F-FDG uptake as a function of radiation dose to normal lung was obtained for each patient. PET image-derived parameters as well as demographic, clinical, treatment and dosimetric patient characteristics were correlated with clinical symptoms of pneumonitis. RESULTS: The dose distributions for the two modalities were significantly different; V5 was higher for IMRT, whereas V60 was higher for protons. The mean lung dose (MLD) was similar for the two modalities. The slope of linear 18F-FDG-uptake - dose response did not differ significantly between the two modalities. The MLD, slope, and 95th percentile of SUV were identified as three major factors associated with radiation pneumonitis. CONCLUSIONS: Despite significantly different dose distributions for IMRT and for protons, the slope of the SUV-dose linear regression line previously shown to be associated with RP did not differ between IMRT and protons. Patients who developed radiation pneumonitis had statistically significantly higher MLD and higher slope regardless of treatment modality.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Shusharina N, Liao Z, Mohan R, et al. Differences in lung injury after IMRT or proton therapy assessed by 18FDG PET imaging. Radiother Oncol. 2018. PMID: 29352608. doi:10.1016/j.radonc.2017.12.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。